Computational study of estrogen receptor-alpha antagonist with three-dimensional quantitative structure-activity...

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Pharmacology

Background:

• Human estrogen receptors (ERα and ERβ) are critical biological targets.
• Understanding ERα ligand binding is crucial for developing therapeutic agents.
• Raloxifene derivatives are investigated for their potential interactions with ERα.

Purpose of the Study:

• To develop Quantitative Structure-Activity Relationship (QSAR) models for predicting ERα inhibitory activity.
• To identify structural features of raloxifene derivatives responsible for ERα binding and modulation.
• To correlate QSAR model descriptors with known biophysical properties of ERα.

Main Methods:

• Employed multiple QSAR modeling techniques: Comparative Molecular Field Analysis (CoMFA), Comparative Molecular Similarity Indices Analysis (CoMSIA), Support Vector Regression (SVR), and Linear Regression (LR).
• Utilized a dataset of 68 raloxifene derivatives to train and validate the models.
• Applied feature selection methods (feature ranking, sequential addition/deletion) to identify significant molecular descriptors for SVR and LR models.

Main Results:

• Developed predictive QSAR models for the inhibitory activity of raloxifene derivatives against ERα.
• Identified 11 key descriptors through feature selection in SVR and LR modeling.
• Found that four descriptors consistently appeared in various models, with two correlating to steric fields (CoMFA, CoMSIA) and two to electrostatic potential of ERα.

Conclusions:

• QSAR modeling effectively predicts the inhibitory activity of raloxifene derivatives against ERα.
• Specific steric and electrostatic features are critical for ERα ligand binding and activity modulation.
• The identified descriptors provide insights into the structural requirements for ERα-targeted drug design.